Navigation Links
Women & Infants earns $3 million grant from National Institutes of Health
Date:11/18/2013

Advances in technology and medical care have dramatically improved survival for infants born prior to 30 weeks gestation and weighing less than three pounds. However, up to 50 percent of these infants may develop physical, cognitive, language and/or behavioral impairments that require extensive health care, educational and psychosocial community resources through adulthood. At this time, there is no reliable method to identify those infants who will go on to develop impairments and those who will not.

Women & Infants Hospital has earned a five-year, $3 million grant from the National Institute of Health's National Institute of Child Health and Human Development to determine the efficacy of a neurobehavioral exam that may help to identify which infants are at greatest risk for developmental impairment. Barry M. Lester, PhD, director of the Brown Center for the Study of Children at Risk at Women & Infants Hospital of Rhode Island and The Warren Alpert Medical School of Brown University, is the principal investigator. Co-principal investigator is T. Michael O'Shea, MD, of Wake Forest University.

Dr. Lester and Edward Tronick, PhD, of the University of Massachusetts, Boston, have developed a neurobehavioral exam called the NNNS, or the NICU (neonatal intensive care unit) Network Neurobehavioral Scale. This exam provides a comprehensive assessment that profiles infant neurobehavior along dimensions that researchers believe will enable them to help identify which infants are at greatest risk for developmental impairment.

"The ability to identify which infants will or will not be developmentally impaired is the 'holy grail' that would usher in a new era of preventive intervention and improve the long term outcome of these fragile babies," said Dr. Lester.

When infants are discharged from the NICU, many who have medical problems become developmentally impaired, while others do not. Likewise, some infants without medical problems become developmentally impaired, while others do not.

"The impairments that are suffered by these children are costly in many ways," explained Dr. Lester. "There is significant emotional cost to the children themselves, their parents and families, including coping with continuous fear and the possibility of crises associated with the infant's unpredictable medical course, extended hospitalizations, and uncertain neurodevelopmental and quality of life outcomes. In addition, time lost from work and other family activities combine to create an enormous burden on the family, their community, support networks, and society in general."

Over a five year period, Dr. Lester and his team will study approximately 1,000 babies born less than 30 weeks gestation at six sites across the country, including at Women & Infants Hospital. These babies will be tested with the NNNS just before discharge from the NICU and then given a series of developmental tests when they are approximately two and one-half years old.

Dr. Lester said, "We will use information about the infants' medical problems and profiles on the NNNS to predict which infants will be developmentally impaired at two and one-half years. If our predictions are accurate, we will be able to use our findings to help early intervention and follow-up programs in their care plans for the baby and to help counseling parents when the baby is discharged from the NICU. Parenting is a key factor in helping babies recover, so parenting will be a critical part of the intervention."

"The long term goal here is prevention," Dr. Lester continued. "If we can identify infants at greatest risk, then we can target interventions to reduce or eliminate later deficits, reduce the pool of infants who need services to only those at greatest risk, and effectively allocate limited resources."


'/>"/>

Contact: Amy Blustein
ablustein@wihri.org
401-681-2822
Women & Infants Hospital
Source:Eurekalert

Related biology news :

1. 2 servings of salmon a week is healthy for pregnant women and their babies
2. American Society of Plant Biologists honors early career women scientists
3. Supplement use predicts folate status in Canadian women
4. Knee injuries in women linked to motion, nervous system differences
5. Women & Infants participating in study of treatment of common viral infection in pregnancy
6. Vitamin D for pregnant women and babies -- how much is enough?
7. Breast cancer in young women: A distinct disease
8. Womens scientific achievements often overlooked and undervalued
9. Brain circuitry is different for women with anorexia and obesity
10. Considerable prevalence of both malaria, STIs exist among pregnant women in sub-Saharan Africa
11. UCSB anthropologists finds high levels of omega-3 fatty acids in breast milk of Amerindian women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology: